Evidence map›Paper›PMID 25293429›Full record

ArticlePediatric cardiology2015

Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience.

Ciji Arthur, Xinyu Tang, Jose R Romero, Jeffrey G Gossett, Nada Harik, Parthak Prodhan

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in oncology · 2021
    Article
  7. Article
  8. Review
  9. High Direct Bilirubin Associated With Levoffoxacin Use in a Neonate.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ciji ArthurDepartment of Pediatric Cardiology, Infectious Diseases, Critical Care, Biostatistics, College of Medicine, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, AR, 72205, USA, carthur@uams.edu.
Xinyu Tang
Jose R Romero
Jeffrey G Gossett
Nada Harik
Parthak Prodhan
University of Arkansas for Medical Sciences · USArkansas Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stenotrophomonas maltophilia can present as bacteremia, respiratory tract infection, urinary tract infection, soft tissue and wound infections, bone and joint infections, meningitis, and endocarditis especially in immunosuppressed patients and those with underlying medical conditions. The incidence and impact of S. maltophilia in young children with heart disease are poorly defined. A single center retrospective observational study was conducted in infants <180 days of age with positive S. maltophilia cultures over a period of 5 years. The overall incidence for S. maltophilia infection was 0.8 % (n = 32/3656). Among 32 identified infants, there were 47 episodes of S. maltophilia infection 66 % of infants had prior exposure to broad spectrum antibiotics. 97 % of positive isolates were susceptible to trimethoprim/sulfamethoxazole and 91 % to levofloxacin as well as ticarcillin/clavulanate. Ventilator-free days and absolute lymphocyte count prior to acquiring infection were significantly lower in non-survivors than in survivors. 100 % of survivors had clearance of positive cultures compared to 50 % in non-survivors (p < 0.05). The crude all-cause mortality rate was 37.5 %. All non-survivors had increased length of ICU stay and duration of mechanical ventilation and had delayed clearance of infection and required longer duration of treatment.

Indexed as

Anti-Bacterial AgentsClavulanic AcidsFemaleGram-Negative Bacterial InfectionsHumansIncidenceInfantInfant, NewbornIntensive Care UnitsLevofloxacinMaleRetrospective StudiesRisk FactorsStenotrophomonas maltophiliaTicarcillinTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsClavulanic AcidsLevofloxacinTicarcillinticarcillin-clavulanic acidTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID25293429
OpenAlexW2016755538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.